CTLA4 and cholangiocarcinoma: There is evidence that Tregs in CCA express CTLA-4 associated protein genes, which may contribute to their immunosuppressive properties, as CTLA-4 can inhibit the activation of CD8+ T cells by binding with CD80 expressed on antigen-presenting cells (Ma et al., 2019).